Literature DB >> 11504408

Rickettsial infection in murine models activates an early anti-rickettsial effect mediated by NK cells and associated with production of gamma interferon.

A N Billings1, H M Feng, J P Olano, D H Walker.   

Abstract

Natural killer (NK) cell activity was significantly increased on days 2-6 of infection in the Rickettsia conorii-infected C3H/HeN mice and on day 2 in the Rickettsia typhi-infected C57BL/6 mice. Depletion of NK cell activity utilizing anti-NK1.1 monoclonal antibody enhanced the susceptibility of normally resistant C57BL/6 mice to infection with R. typhi, and depletion of NK cell activity with antibody to asialo GM1 enhanced the susceptibility of C3H/HeN mice to infection with R. conorii. Serum gamma interferon was increased in R. conorii-infected C3H/HeN mice compared with NK cell-depleted, infected mice during the early course of infection. Additionally, the NK cell activating cytokine IL-12 was elevated in the sera of infected mice during the time period representing enhanced NK cell activity compared with uninfected mice. Thus, it appears that NK cells contribute to the early anti-rickettsial immune response, likely via a mechanism involving gamma interferon.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11504408     DOI: 10.4269/ajtmh.2001.65.52

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  23 in total

1.  The Rickettsia conorii autotransporter protein Sca1 promotes adherence to nonphagocytic mammalian cells.

Authors:  Sean P Riley; Kenneth C Goh; Timothy M Hermanas; Marissa M Cardwell; Yvonne G Y Chan; Juan J Martinez
Journal:  Infect Immun       Date:  2010-02-22       Impact factor: 3.441

2.  Persisting Rickettsia typhi Causes Fatal Central Nervous System Inflammation.

Authors:  Anke Osterloh; Stefanie Papp; Kristin Moderzynski; Svenja Kuehl; Ulricke Richardt; Bernhard Fleischer
Journal:  Infect Immun       Date:  2016-04-22       Impact factor: 3.441

Review 3.  Recent molecular insights into rickettsial pathogenesis and immunity.

Authors:  Sanjeev K Sahni; Hema P Narra; Abha Sahni; David H Walker
Journal:  Future Microbiol       Date:  2013-10       Impact factor: 3.165

4.  Contribution of NK cells to the innate phase of host protection against an intracellular bacterium targeting systemic endothelium.

Authors:  Rong Fang; Nahed Ismail; David H Walker
Journal:  Am J Pathol       Date:  2012-05-19       Impact factor: 4.307

5.  Expression of CX3CL1 (fractalkine) in mice with endothelial-target rickettsial infection of the spotted-fever group.

Authors:  Gustavo Valbuena; David H Walker
Journal:  Virchows Arch       Date:  2004-10-05       Impact factor: 4.064

6.  Rickettsiae stimulate dendritic cells through toll-like receptor 4, leading to enhanced NK cell activation in vivo.

Authors:  Jeffrey M Jordan; Michael E Woods; Lynn Soong; David H Walker
Journal:  J Infect Dis       Date:  2009-01-15       Impact factor: 5.226

Review 7.  Pathogenesis of Rickettsial Diseases: Pathogenic and Immune Mechanisms of an Endotheliotropic Infection.

Authors:  Abha Sahni; Rong Fang; Sanjeev K Sahni; David H Walker
Journal:  Annu Rev Pathol       Date:  2018-08-27       Impact factor: 23.472

Review 8.  The realities of biodefense vaccines against Rickettsia.

Authors:  David H Walker
Journal:  Vaccine       Date:  2009-11-05       Impact factor: 3.641

9.  Expression analysis of the T-cell-targeting chemokines CXCL9 and CXCL10 in mice and humans with endothelial infections caused by rickettsiae of the spotted fever group.

Authors:  Gustavo Valbuena; William Bradford; David H Walker
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

10.  Relevance of gamma interferon, tumor necrosis factor alpha, and interleukin-10 gene polymorphisms to susceptibility to Mediterranean spotted fever.

Authors:  Giusi Irma Forte; Letizia Scola; Gabriella Misiano; Salvatore Milano; Pasquale Mansueto; Giustina Vitale; Fiamma Bellanca; Maria Sanacore; Loredana Vaccarino; Giovan Battista Rini; Calogero Caruso; Enrico Cillari; Domenico Lio; Serafino Mansueto
Journal:  Clin Vaccine Immunol       Date:  2009-04-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.